Delivery Order SPE2DB22D2006-SPE2DB23FW0SB

Award Date 6/24/23
Potential Completion Date 6/26/23
Potential Value $53
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $19,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562193494, described as Bumetanide 1 mg/4 ml vials in 4 ml quantities. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 15, 2023 through September 18, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
The Defense Logistics Agency awarded a $19,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562193492 BUMETANIDE 1 MG/4 ML VIAL 4ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products from its location in Conshohocken, Pennsylvania to the Defense Logistics Agency between September 15-18, 2023. The Defense Logistics Agency is the logistics combat support agency of the Department...
The Defense Logistics Agency awarded a $19,520 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562193502 Bumetanide 1 mg/4 ml vials. The firm fixed price order is for 4 ml vials of the diuretic medication to be delivered to a facility in Conshohocken, Pennsylvania between September 15-18, 2023. Amerisourcebergen will serve as the prime contractor, with performance taking place at its Corporate Office Division location. The funding agency, DLA, manages the Department of...
The Defense Logistics Agency awarded a $922 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4562232735, described as Bumetanide 2.5 mg/10 ml vials packaged in quantities of 10 ml. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania over a four-day period concluding on September 20, 2023. No set aside designation or subcontracting arrangements were specified. The Defense Logistics Agency manages the global supply chain for the...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $22,680 to Amerisourcebergen Drug Corporation for 100 tablets of bumetanide 1 mg. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the order through its Conshohocken, Pennsylvania facility by August 14, 2023. The Defense Logistics Agency leverages contracts such as this to efficiently procure pharmaceuticals in direct support of U.S. military healthcare programs. No...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $8,540 to Amerisourcebergen Drug Corporation to supply 100 tablets of 2 mg bumetanide each. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. No major subcontractors or set aside designations were indicated. This order is consistent with DLA's mission to provide logistics support for medical commodities...
The Defense Logistics Agency awarded a $19,520 delivery order to Amerisourcebergen Drug Corporation for 4,562,193,484 units of bumetanide 1 mg/4 ml vials. The firm fixed price order is being fulfilled under the Prime Vendor Program prime vendor contract vehicle. Amerisourcebergen will deliver the pharmaceutical products to a customer located in Conshohocken, Pennsylvania by September 18, 2023 from its facility in the same area. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-two thousand four hundred forty-nine dollars to Amerisourcebergen Drug Corporation for five hundred units of two milligram bumetanide tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for product delivery between August eighth and ninth of twenty twenty-three under an existing Amerisourcebergen contract vehicle. As a leading provider of pharmaceuticals...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $331.34 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of bumetanide 1 mg to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 27, 2023 in support of the Agency's medical supply needs. As a top tier subcontractor to DLA, Amerisourcebergen will fulfill this requirement for the diuretic medication from its existing pharmaceutical distribution contract vehicles....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred dollars and thirty-eight cents to Amerisourcebergen Drug Corporation for bumetanide tablets. As the prime contractor, Amerisourcebergen will supply one hundred tablets of the 1 mg dosage to a facility located in Conshohocken, Pennsylvania by August 11, 2023 to fulfill requirements under the agency's pharmaceutical procurement programs. No subcontractors or set aside designations were indicated. The order...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB23FW0SB
    Delivery Order

The Defense Logistics Agency awarded a $52,870 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561332421 BUMETANIDE 2.5 MG/10 ML VIAL 10ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania by June 26, 2023 in support of the Defense Logistics Agency's medical supply chain operations. No major subcontractors or set aside designations were identified. The delivery order was awarded against an existing DLA pharmaceuticals contract vehicle to fulfill critical medication needs for the Department of Defense.

Generated 12/20/23, 12:42 AM